Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Talquetamab may cause hair loss and skin issues.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Intralesional methotrexate and triamcinolone acetonide are more effective than Vitamin D3 for treating alopecia areata.

Topical tacrolimus is safe and effective for skin conditions, but oral tacrolimus has serious side effects.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Triamcinolone is more effective than methotrexate for treating localized alopecia areata.

Tislelizumab can cause cutaneous lupus erythematosus.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

The combination therapy was effective and well-tolerated, especially in young patients.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Bimekizumab can improve scarring alopecia in severe psoriasis.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Combining cytostatic and steroid drugs effectively treats systemic lupus erythematosus.

The topical treatment WR 279,396 effectively healed cutaneous leishmaniasis in mice without relapse.

Protein-losing enteropathy worsened with lupus symptoms but improved with prednisolone.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.